National health expenditures are projected to grow an average 5.5 percent annually during 2018-2027, outpacing average projected growth in gross domestic product by 0.8 percentage point, the Centers for Medicare & Medicaid Services’ Office of the Actuary reported today. While the insured population is expected to remain around 90 percent throughout the period, average annual Medicare spending (7.4 percent) is expected to exceed that in Medicaid (5.5 percent) and private health insurance (4.8 percent) as baby-boomers continue to age into the program, the agency said. Prices for health care goods and services are projected to grow an average 2.5 percent per year. Spending for hospital services and for physician and clinical services are expected to grow an average 5.6 percent and 5.4 percent, respectively, per year, which includes the cost of prescription drugs administered in those settings. Spending for retail prescription drugs is expected to grow an average 5.6 percent per year. Population growth and the changing age-sex mix of the population account for over two thirds of the projected spending growth.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
One in five Medicaid enrollees have been disenrolled since continuous coverage ended last March, a quarter of whom remain uninsured, according to a poll…
Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…